logo-small.png
- BLOG -

Headquarters

501 Boylston Street, 10th Floor

Boston, MA 02116

(617)-737-5000

info@outsidegc.com

ON-DEMAND INSIGHTS

Key Issues in Commercial Real Estate Leases for Life Sciences Tenants

Key Issues in Commercial Real Estate Leases for Life Sciences Tenants

April 9, 2019 at 2:44 PM - Life Sciences,

The commercial real estate needs of life sciences companies (pharma, biotech, medical device) are both varied and complex. While start-ups tend to seek small generic lab space, more established enterprises typically require large build-to-suit spaces in which to house their state-of-the-art production facilities. Similarly diverse are life sciences landlords, who range in size from large REITs to real estate developers and even smaller building owners looking to convert their buildings into lab space in the low vacancy rate areas where such tenants tend to cluster. 

Continue Reading
Negotiating a

Negotiating a "Win-Win" in Pharmaceutical Contract Manufacturing

March 7, 2019 at 9:47 AM - Life Sciences,

In an earlier post, we explored some of the key issues in a contract manufacturing agreement from the perspective of the drug developer. However, Outside GC frequently represents outsourced manufacturers, too. The knowledge we’ve gained from working on both sides of the table enables us to effectively and efficiently negotiate agreements that satisfy both parties.

Continue Reading
The Changing Landscape for Off-Label Promotion

The Changing Landscape for Off-Label Promotion

April 19, 2016 at 2:52 PM - Life Sciences

 

Imagine your child or spouse is suffering from an illness with few effective treatment options, such as a rare pediatric cancer or autoimmune disease. Meanwhile, a team of doctors and researchers has been steadily working to unlock the mysteries of this disease for years, in an ongoing effort to identify better solutions for patients.  The team has just published promising results from a recent study in a respected medical journal. The study involved so-called “off-label use” of a prescription drug for these patients, i.e. administering a drug already approved by FDA, on the market, and prescribed by doctors for a related but different medical condition. 

Continue Reading

Subscribe to our Blog

Popular Posts

   
This publication should not be construed as legal advice or a legal opinion on any specific facts or circumstances nor an offer to represent you. It is not intended to create, and receipt does not constitute, an attorney-client relationship. The contents are intended for general informational purposes only, and you are urged to consult your attorney concerning any particular situation and any specific legal questions you may have. Pursuant to applicable rules of professional conduct, portions of this publication may constitute Attorney Advertising.

Outside GC is an innovative approach to legal services for growing and mature businesses. Companies who engage Outside GC fall into two main categories: (1) those without in-house counsel who need regular, on-going legal support but do not wish to hire a full-time in-house lawyer, and (2) those with in-house counsel who do not wish to add more full-time resources to their existing in-house staff. Contact us to speak to one of our on-demand attorneys.